I'm glad you called out Google in your post. I joined Google in 2015 having been a managing director of a global software engineering team at a non-tech F500, where I had teams in Brazil, India, China and Mexico, and folks scattered around the US & Scotland. I was accustomed for the prior ten years of my career, to run my org basically how you described, and I like to think I was a good manager that my team respected, and that we generally operated well. I spent a lot of my time 1) in leadership meetings trying to understand strategy and business requirements, and 2) structuring projects for my org and mentoring key individuals.
At Google, I found there to be 0 respect for management as a function. Every manager is expected to have their own personal projects and come performance review season you had better be able to point to something you did yourself, not just the outcomes you managed through your team. Perhaps this worked when it was a startup, but as an enterprise with roughly 350,000 workers, it's disrespectful to leaders to run things like this. I expect Bayer to experience similar disillusionment among their experienced management team. Overall they will probably see tactical acceleration in some areas but breakdowns in many others that will be more systemic and harder to recover from.
At Google, I found there to be 0 respect for management as a function. Every manager is expected to have their own personal projects and come performance review season you had better be able to point to something you did yourself, not just the outcomes you managed through your team. Perhaps this worked when it was a startup, but as an enterprise with roughly 350,000 workers, it's disrespectful to leaders to run things like this. I expect Bayer to experience similar disillusionment among their experienced management team. Overall they will probably see tactical acceleration in some areas but breakdowns in many others that will be more systemic and harder to recover from.